MedTrace Logo

Development of a Cell Culture Process for the Production of Human T-lymphocyte Precursors

NCT05118113 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2023-11-21

No results posted yet for this study

Summary

The purpose of this study is to finalise the development of a process for the production of T-cell progenitor cells.

Conditions

  • Healthy Volunteers

Interventions

PROCEDURE

Collection of mobilized hematopoietic stem cells (apheresis products) from healthy volunteers

Mobilisation of hematopoietic stem cells by injection of filgrastim (authorized auxiliary medicinal product) for 4 consecutive days and leukapheresis on Day 5

Sponsors & Collaborators

  • Smart Immune SAS

    lead INDUSTRY

Principal Investigators

  • Joe-Elie Salem, MD, PhD · CIC Paris Est, Hôpital Pitié Salpêtrière, Paris

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-26
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05118113 on ClinicalTrials.gov